DE3275269D1 - Stabilization of 1-substituted imidazole derivatives in talc - Google Patents

Stabilization of 1-substituted imidazole derivatives in talc

Info

Publication number
DE3275269D1
DE3275269D1 DE8282103685T DE3275269T DE3275269D1 DE 3275269 D1 DE3275269 D1 DE 3275269D1 DE 8282103685 T DE8282103685 T DE 8282103685T DE 3275269 T DE3275269 T DE 3275269T DE 3275269 D1 DE3275269 D1 DE 3275269D1
Authority
DE
Germany
Prior art keywords
talc
substituted imidazole
stabilization
imidazole derivatives
stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282103685T
Other languages
English (en)
Inventor
Benjamin Eric Joel
Lee Maryann Ott
Lin Lih-Yang Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Application granted granted Critical
Publication of DE3275269D1 publication Critical patent/DE3275269D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE8282103685T 1981-04-30 1982-04-29 Stabilization of 1-substituted imidazole derivatives in talc Expired DE3275269D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/259,228 US4382091A (en) 1981-04-30 1981-04-30 Stabilization of 1-substituted imidazole derivatives in talc

Publications (1)

Publication Number Publication Date
DE3275269D1 true DE3275269D1 (en) 1987-03-05

Family

ID=22984086

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282103685T Expired DE3275269D1 (en) 1981-04-30 1982-04-29 Stabilization of 1-substituted imidazole derivatives in talc

Country Status (4)

Country Link
US (1) US4382091A (de)
EP (1) EP0064283B1 (de)
AT (1) ATE25196T1 (de)
DE (1) DE3275269D1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935410A (en) * 1983-03-31 1990-06-19 Rhone-Poulenc Agrochimie S.A. Fungicidal aluminum tris-alkyl-phosphonate composition
FR2543405B1 (fr) * 1983-03-31 1986-01-03 Rhone Poulenc Agrochimie Composition fongicide a base de tris ethyl phosphonate d'aluminium
JPH0653658B2 (ja) * 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
KR950010150B1 (ko) * 1986-01-14 1995-09-11 쥬우가이세이야꾸 가부시끼가이샤 니코란딜 함유 주사제의 안정화 방법
KR940000232B1 (ko) * 1986-01-17 1994-01-12 쥬우가이세이야꾸 가부시끼가이샤 니코란딜 제제의 안정화 방법
US5433959A (en) * 1986-02-13 1995-07-18 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
US6749864B2 (en) 1986-02-13 2004-06-15 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
LT2508B (lt) * 1986-08-15 1994-02-15 American Cyanamid Co Herbicidine kompozicija
ZA934007B (en) * 1992-06-08 1994-03-09 Schering Plough Healthcare Stable imidazole anti-fungal powder compositions
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
EA030606B1 (ru) 2006-05-04 2018-08-31 Бёрингер Ингельхайм Интернациональ Гмбх Способы приготовления лекарственного средства, содержащего полиморфы
EP1852108A1 (de) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG Zusammensetzungen von DPP-IV-Inhibitoren
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EP3542801A1 (de) * 2007-08-17 2019-09-25 Boehringer Ingelheim International GmbH Purinderivate zur verwendung bei der behandlung von fap-bedingten erkrankungen
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
PE20110297A1 (es) * 2008-08-15 2011-05-26 Boehringer Ingelheim Int Inhibidores de dpp-4 para la cicatrizacion de heridas
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
JP2012512848A (ja) 2008-12-23 2012-06-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 有機化合物の塩の形態
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
BR112012012641A2 (pt) 2009-11-27 2020-08-11 Boehringer Ingelheim International Gmbh TRATAMENTO DE PACIENTES DIABÉTICOS GENOTIPADOS COM INIBIDORES DE DPP-lVTAL COMO LINAGLIPTINA
WO2011138421A1 (en) 2010-05-05 2011-11-10 Boehringer Ingelheim International Gmbh Combination therapy
EP3366304B1 (de) 2010-06-24 2020-05-13 Boehringer Ingelheim International GmbH Diabetestherapie
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
WO2013010964A1 (en) 2011-07-15 2013-01-24 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
WO2013171167A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
ES2950384T3 (es) 2014-02-28 2023-10-09 Boehringer Ingelheim Int Uso médico de un inhibidor de DPP-4
EP3468562A1 (de) 2016-06-10 2019-04-17 Boehringer Ingelheim International GmbH Kombinationen aus linagliptin und metformin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR906046A (fr) * 1942-11-25 1945-12-20 Ig Farbenindustrie Ag Poudre pour lutter contre les poux de corps et autre vermine
US3133866A (en) * 1959-08-31 1964-05-19 Johnson & Johnson Dusting powder composition containing salts of poly basic phosphoric acids
US3801709A (en) 1970-10-27 1974-04-02 Johnson & Johnson Fragrance retention by chelating agent coated talc
US4055652A (en) * 1975-07-07 1977-10-25 Syntex (U.S.A.) Inc. 1-[β(R-thio)phenethyl]imidazoles and derivatives thereof
US4078071A (en) * 1976-03-08 1978-03-07 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkyl imidazoles
US4185086A (en) 1978-05-04 1980-01-22 Johnson & Johnson Talc compositions
US4277475A (en) * 1979-01-11 1981-07-07 Syntex (U.S.A.) Inc. Contraceptive methods employing 1-substituted imidazole derivatives

Also Published As

Publication number Publication date
US4382091A (en) 1983-05-03
EP0064283B1 (de) 1987-01-28
EP0064283A2 (de) 1982-11-10
ATE25196T1 (de) 1987-02-15
EP0064283A3 (en) 1983-07-20

Similar Documents

Publication Publication Date Title
DE3275269D1 (en) Stabilization of 1-substituted imidazole derivatives in talc
GB8518818D0 (en) Carbapenem derivatives
YU54189A (en) Process for obtaining cephem derivatives and midproducts for the same
GB1236735A (en) Fungicidal agents and methods
ES8609273A1 (es) Un procedimiento para preparar nuevos derivados de ciano-2- bencimidazol
AU554279B2 (en) Cycloalkyl (alpha-triazolyl-beta-hydroxy)-ketones
HUT37711A (en) Fungicide compositions containing 1,2,4-triazol-1-yl-methyl-carbonil derivatives as active substances and process for preparing 1,2,4-triazol-1-yl-methyl-carbonil derivatives
AU3070984A (en) 3-(1, 2, 4-triazol-1-yl)-prop-1-enes
IE56917B1 (en) N-sulphenylated hydantoins,a process for their preparation and their use as microbicides
ES8205219A1 (es) Un metodo para producir un compuesto de hidrouracilo
NZ215772A (en) Heterocyclic amide derivatives and fungicidal compositions
GR74782B (de)
ZA939604B (en) Imidazole derivatives
JPS53148530A (en) Agricultural and horticultural fungicide
GR79114B (de)
AR246737A1 (es) Complejos fungicidas imidazolicos
JPS5325590A (en) 7-(n-substituted alkanoyl-2-phenylglycineamide)-cephalosporanic acid derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition